Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | JAB-21822 |
Trade Name | |
Synonyms | JAB21822|JAB 21822 |
Drug Descriptions |
JAB-21822 is an inhibitor of KRAS G12C, with potential antitumor activity (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 3089-3089). |
DrugClasses | KRAS G12C inhibitor 28 |
CAS Registry Number | NA |
NCIT ID | C181904 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + JAB-21822 | Cetuximab JAB-21822 | 0 | 1 |
JAB-21822 | JAB-21822 | 0 | 1 |